XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 861 $ 4,635
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 5,323
Right-of-use asset amortization 91 68
Amortization of debt issuance costs 248 15
Deferred income taxes 229 (122)
Change in fair value of warrants 95 982
Loss on exercise of warrants 143
Foreign currency transaction (gain) loss (918) 186
Realized loss on sale of marketable investments 231
Loan discount and fee accretion on finance receivables (1,256) (1,466)
Interest paid-in-kind (478) (351)
Stock-based compensation 111 35
Depreciation and amortization 514 648
Changes in operating assets and liabilities:    
Interest, accounts, and other receivables (1,623) (1,251)
Derivative assets and liabilities, net 831 (388)
Other assets (283) (915)
Accounts payable and other liabilities 311 (1,412)
Net cash provided by operating activities 4,430 664
Cash flows from investing activities:    
Sale of marketable investments 258
Investment in finance receivables (446) (12,990)
Repayment of finance receivables 9,362 1,906
Corporate debt securities principal payments 7 10
Purchases of property and equipment (8)
Net cash provided by (used in) investing activities 9,181 (11,082)
Cash flows from financing activities:    
Net (payments on) proceeds from credit facility (12,350) 8,037
Repurchases of common stock, including fees and expenses (999) (531)
Net cash (used in) provided by financing activities (13,349) 7,506
Net increase (decrease) in cash, cash equivalents, and restricted cash 262 (2,912)
Cash, cash equivalents, and restricted cash at beginning of period 5,236 6,156
Cash, cash equivalents, and restricted cash at end of period $ 5,498 $ 3,244